ACHV stock: buy or sell?

ACHV stock price: $2.24 6.16% At close on September 20th, 2019

Updated on:
September 20th, 2019

0

Achieve Life Sciences shares boosted 6.16% to $2.24 today. On Sep/12 ACHV collapsed a bloodcurdling -5.50%.

Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients.

Should I buy ACHV stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

None of our preferred buy setups matches with Achieve Life Sciences stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Achieve Life Sciences stock a buy?

Banks and financial institutions post stock ratings everyday. At Stocks2.com, we detected 4 ratings published for ACHV stock in the last 30 days.

The general sentiment of these ratings is bullish for ACHV stock, with 4 positive ratings.
Is ACHV a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-9LADENBURG THALM/SH SHn/aBuy
2019-7-24Maxim Groupn/aBuy
2019-6-14Maxim Groupn/aBuy
2019-6-11LADENBURG THALM/SH SHPositiveBuy

ACHV stock analysis

Daily outlook

Achieve Life Sciences shares boosted 6.16% to $2.24 today.

Shares of Achieve Life Sciences closed today at $2.24 and boosted a dazzling 6.16%. From a daily outlook perspective, ACHV is drawing an uptrend of rising tops and rising bottoms. Since its last top on Sep/10 at $2.51, price slid and found support around $2.07. Breaking down under $2.07 would cancel the current uptrend and it might slide further to test lower supports. Note that $2.51 might act as a resistance line. Trading the long side, we should wait to a new breakout over $2.51 to find the next buy point. Since SMA100d and SMA200d crossed up on May, ACHV price slid a -45.76%.

ACHV stock chart (daily)

Weekly outlook

Achieve Life Sciences ended this week at $2.24 and declined an unpleasant -0.88%. Early September ACHV boosted an astounding 13.48% in just one week.

The downtrend marked by ACHV has left successive falling tops and bottoms. If the support holds the price, this might mark a double bottom configuration and create a flat-base to reverse this downtrend. Since mid June, when ACHV stock price broke down the 40-weeks moving avarage line, it slid $-1.42 per share (-38.80%). Stocks under the 40w moving average line are usually not recommended for average traders. Since late April when SMA20w and SMA40w crossed up, ACHV price slipped $-2.11 per share (-48.51%).

ACHV stock chart (weekly)

ACHV stock price history

ACHV IPO was on October 13th, 2000 at $1,670.63 per share1. Since then, ACHV stock declined a -99.90%, with a yearly average of -5.60%.

1: Adjusted price after possible price splits or reverse-splits.

ACHV stock historical price chart

ACHV stock reached 52-week highs on September at $5.25, and all-time highs 2005-10-18 with a price of 9979.2.

ACHV stock price target is $13.00

How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We have 4 price targets for ACHV stock posted in the last 30 days:
ACHV stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-8-9LADENBURG THALM/SH SHReiteratesn/a$20.00-
2019-7-24Maxim GroupReiteratesn/a$6.00-
2019-6-14Maxim GroupInitiatesn/a$6.00-
2019-6-11LADENBURG THALM/SH SHReiterates$12.00$20.0066.7%
(in average)$12.00$13.008.0%
The price forecast for Achieve Life Sciences stock is $13.00, moving in a range between $20.00 and $6.00. In average, analysts' outlook on ACHV price forecast is positive, improving the prediction by a 8.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

Since last March, when Achieve Life Sciences published its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will update this review.
ACHV earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a-0.11n/a
2017-Q2-n/a-0.08n/a
2017-Q3-n/a-0.25n/a
2017-Q42018-03-01n/a-3.2n/a
2018-Q12018-05-09n/a-2.4n/a
2018-Q22018-08-08n/a-1.82n/a
2018-Q32018-11-07n/a-0.71n/a
2018-Q42019-03-14n/a-0.55n/a
2019-Q1-n/an/an/a
2019-Q2-n/an/an/a

Annual financial results

Compared to 2015, last anual turnover report draw a dreadful slide of -72.13% to $5.06 million USD. When comparing 2016 vs 2015, in line, profit margin (that is, the net income divided by revenues) collapsed a -305.13% to -397.65%.

ACHV annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$30 M-$-31.85 M-106.6%-
2014$27 M-9.25%$-26.24 M-96.8%-17.61%
2015$18 M-33.03%$-16.80 M-92.5%-35.97%
2016$5.06 M-72.13%$-20.13 M-397.6%19.81%

Quarterly financial results

Reported quarter income marked $-3.64 million with a profit margin of . Profit margin remained steady a 0.00% compared to previous quarter when profit margin was inf%. When comparing turnover to same quarter last year, Achieve Life Sciences sales marked a neutral move and remained stable a nan%. Looking back to recent quarterly results, Achieve Life Sciences posted 7 negative quarters in a row.
ACHV quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2

Achieve Life Sciences ownership

When you are planning to invest in shares of a stock, it's always worth to have a look its ownership structure.

Achieve Life Sciences shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 4.97% of all shares.

In case of Achieve Life Sciences stock, 28.42% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ACHV stock account 0.00%, no big difference from last month.

For a better understanding, the next table shows ownership data compared to other related stocks:

ACHV
Market cap$18.1 M
Total shares8.1 M
Float shares7.2 M
  - Institutional holdings (%)28.4%
  - Insider holdings (%)5.0%
Shares in short selling0.0%

ACHV summary

Friday, September 20th, 2019
Open$2.09
Close$2.24
Day range$2.05 - $2.29
Previous close$2.11
Session gain6.16%
Average true range$0.18
50d mov avg$1.97
100d mov avg$2.58
200d mov avg$2.42
Daily patternlb03a
Weekly pattern lt02a

Achieve Life Sciences performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Achieve Life Sciences, the comparison is made against .
Stock3m6m12m
ACHVAchieve Life Scie...-3.45%-20.85%-10.04%

Achieve Life Sciences competitors

Unfortunately, we could not find any public company that could be defined as Achieve Life Sciences competitor. This doesn't mean Achieve Life Sciences does not have any competitor in the market, it's just we could not detected it.